E. Wassenaar

发表

Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned

J. V. van Sandick, C. Hahn, K. Hartemink, 2021, Annals of Surgical Oncology.

Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging

F. Giesel, R. Fodde, J. Koster, 2022, British Journal of Cancer.

Exhaustion of the immune system by Group A Streptococcus necrotizing fasciitis: the occurrence of late secondary infections in a retrospective study

J. Wille, F. Hietbrink, L. Leenen, 2019, Trauma Surgery & Acute Care Open.

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)

M. Lahaye, J. Burger, I. de Hingh, 2019, BMJ Open.

Tumor characteristics and clinical outcome of peritoneal metastasis of gastric origin treated with a hyperthermic intraperitoneal chemotherapy procedure in the PERISCOPE I trial

K. Sikorska, J. V. van Sandick, M. Los, 2021, Journal of surgical oncology.

Treatment of PERItoneal disease in Stomach Cancer with cytOreductive surgery and hyperthermic intraPEritoneal chemotherapy: PERISCOPE I initial results

J. Schellens, K. Sikorska, J. V. van Sandick, 2020, The British journal of surgery.

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy

I. B. Borel Rinkes, G. Kops, O. Kranenburg, 2019, The British journal of surgery.

The impact of radiological retroperitoneal lymphadenopathy on survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases.

A. Aalbers, B. van Ramshorst, F. Lalezari, 2019, European Journal of Surgical Oncology.

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid

G. Meijer, C. Punt, M. Lahaye, 2021, The journal of pathology. Clinical research.

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity

J. Koster, J. Laoukili, A. Huitema, 2022, British Journal of Cancer.

Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)

J. Burger, F. Mols, I. de Hingh, 2021, Surgical Endoscopy.

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)

J. Burger, I. de Hingh, M. Los, 2021, BMJ Open.

Pressurized Intraperitoneal Aerosol Chemotherapy (Oxaliplatin) for Unresectable Colorectal Peritoneal Metastases: A Multicenter, Single-Arm, Phase II Trial (CRC-PIPAC)

M. Lahaye, J. Burger, I. de Hingh, 2021, Annals of Surgical Oncology.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

A. Zwinderman, J. Tuynman, R. Fehrmann, 2019, BMC Cancer.

Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases

Johannes G. Reiter, Shriya V. Nagpal, J. Lennerz, 2020, Nature Genetics.

Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study)

F. Daams, R. van Hillegersberg, H. V. van Stel, 2018, BMC Cancer.

Lymph node metastases develop through a wider evolutionary bottleneck than distant metastases

Johannes G. Reiter, Shriya V. Nagpal, J. Lennerz, 2020, Nature Genetics.

Systemic Pharmacokinetics of Oxaliplatin After Intraperitoneal Administration by Electrostatic Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC) in Patients with Unresectable Colorectal Peritoneal Metastases in the CRC-PIPAC Trial

J. Burger, M. Deenen, D. Boerma, 2020, Annals of Surgical Oncology.

Systemic exposure of oxaliplatin and docetaxel in gastric cancer patients with peritonitis carcinomatosis treated with intraperitoneal hyperthermic chemotherapy.

H. Rosing, J. V. van Sandick, J. Schellens, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Composition of the cellular infiltrate in patients with simple and complex appendicitis.

J. Roelofs, H. Heij, M. Bunders, 2017, The Journal of surgical research.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

A. Zwinderman, J. Tuynman, R. Fehrmann, 2019, BMC Cancer.

The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer

E. Consten, W. Bemelman, J. Heemskerk, 2022, Modern Pathology.

Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial

J. Tuynman, J. Heemskerk, A. Aalbers, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II).

M. Los, S. Elias, G. Creemers, 2024, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.